I define market-leading product strategies that translate into high-velocity delivery roadmaps. With 20+ years of leadership, I specialize in transforming complex commercial visions into AI-native platforms and advising PE-backed organizations on the innovation-to-execution bridge.
Deep roots in clinical workflow and EHR ecosystems. Expert in translating clinical necessity into high-adoption technology.
Scaling AI platforms that reduce administrative waste and improve health plan intelligence for national payers.
Commercialization of product offerings across the complete pharmaceutical value chain—Discovery, Development, Launch, and Market.
2026 — Present
Acting as a strategic partner to private equity firms and healthcare founders, specializing in AI-led product transformation and commercial scaling. Through Airloom Health, I architect the infrastructure required to bridge fragmented market gaps, translating deep R&D into actionable growth strategies for enterprise platforms.
2024 — 2026
Defined and delivered a 0-1 product strategy. Translated enterprise vision into engineering-ready roadmaps, secured two national health plan investors, and managed a $20M operating budget to build a 35-person product organization from scratch.
2022 — 2023
Spearheaded the product-led transformation for a PE-backed Real-World Data company. Redefined the commercial roadmap to align with pharma R&D needs, facilitating a successful acquisition by Zephyr AI.
2019 — 2022
Owned P&L for a $150M multi-product portfolio. Scaled the product team from 8 to 25, achieved 2x revenue growth, and drove significant bottom-line efficiency by aligning global product roadmaps with enterprise commercial cycles.
An exclusive forum hosted by CPO Track and Intellias for NYC's Chief Product Officers. Melissa joins fellow executive leaders to discuss architecting AI-led innovation and scaling high-velocity engineering partnerships.
Perspective
Reflections on a 20-year career transforming healthcare through technology, published by Boston University.